02.05.2014 Views

Gram-negative folliculitis. a rare problem or is it - Our Dermatology ...

Gram-negative folliculitis. a rare problem or is it - Our Dermatology ...

Gram-negative folliculitis. a rare problem or is it - Our Dermatology ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Leyden et al [9], clinically differentiated two types of<br />

GNF. The type I, superficial <strong>or</strong> pustular, <strong>is</strong> the most<br />

common (80-90%), w<strong>it</strong>h presence of multiple papules<br />

and pustules in the middle of the face, 3 to 6 mm in<br />

diameter w<strong>it</strong>h an erythematous halo, mainly caused by E.<br />

coli, Klebsiella sp., Enterobacter sp. and P. aeruginosa.<br />

The type II, deep <strong>or</strong> nodular (10-20%), <strong>is</strong> characterized<br />

by deep and painfully inflammat<strong>or</strong>y nodules <strong>or</strong> cysts, on<br />

the face, neck and/<strong>or</strong> chest, caused by Proteus mirabil<strong>is</strong>.<br />

Sebaceous follicles are colonized w<strong>it</strong>h these bacteria,<br />

mainly in the peri<strong>or</strong>al and perinasal zone, w<strong>it</strong>h<br />

subsequent follicular and perifollicular inflammation<br />

w<strong>it</strong>h f<strong>or</strong>mation of papules and pustules [3,4,10,11].<br />

Marples et al [12], confirmed an inverse ratio between<br />

nasal carriers of S. aureus and enterobacteria. The<br />

prop<strong>or</strong>tion of <strong>Gram</strong>-<strong>negative</strong> bacteria results in a 1% of<br />

the total fl<strong>or</strong>a under n<strong>or</strong>mal cond<strong>it</strong>ions. In the case of<br />

nasal carriers th<strong>is</strong> ratio increases 3-4%, being nasal<br />

cav<strong>it</strong>y the reservoir f<strong>or</strong> facial cases of GNF [2,3].<br />

The role of immune mechan<strong>is</strong>ms of defense as a fact<strong>or</strong> in<br />

the development of the GNF in patients w<strong>it</strong>h acne <strong>is</strong> not<br />

clear yet. Neubert et al [3], rep<strong>or</strong>t that in add<strong>it</strong>ion to<br />

seb<strong>or</strong>rhea and microfl<strong>or</strong>a changes induced by antibiotics,<br />

there are various mechan<strong>is</strong>ms in the host immune<br />

defense, which appear to be an imp<strong>or</strong>tant fact<strong>or</strong> in the<br />

GNF, induced by a depressed cell-mediated immun<strong>it</strong>y, as<br />

evidenced by weak <strong>or</strong> absent response of<br />

hypersens<strong>it</strong>iv<strong>it</strong>y, which results in increased susceptibil<strong>it</strong>y<br />

to infections, showing a decrease of serum IgM, w<strong>it</strong>h a<br />

weak <strong>or</strong> absent response to enterobacterial antigens,<br />

similar events occur in patients w<strong>it</strong>h type V<br />

dysgammaglobulinemia (selective deficiency of IgM),<br />

which are liable to septicemia ep<strong>is</strong>odes by <strong>Gram</strong><strong>negative</strong><br />

bacteria, and a deficiency in the complement<br />

system causing alterations in opsonization, chemotax<strong>is</strong><br />

and bacterial lys<strong>is</strong>. There <strong>is</strong> also evidence that<br />

chemotax<strong>is</strong> of neutrophils may be inhib<strong>it</strong>ed by IgEmediated<br />

h<strong>is</strong>tamine release, which <strong>is</strong> elevated in these<br />

patients.<br />

It <strong>is</strong> well known that tetracyclines, the most commonly<br />

used systemic antibiotic in acne and rosacea, impair<br />

protein synthes<strong>is</strong> and function of lymphocytes and<br />

neutrophil chemotax<strong>is</strong>, increasing the r<strong>is</strong>k of bacterial<br />

infection [3,4].<br />

The diagnos<strong>is</strong> should be confirmed w<strong>it</strong>h a smear of the<br />

pustules. The lesions (pustules) and the anteri<strong>or</strong> nasal<br />

mucosa should be sampled f<strong>or</strong> bacteriological studies.<br />

Treatment antibiotics must be w<strong>it</strong>hdrawn [4,10]. Oral<br />

<strong>is</strong>otretinoin <strong>is</strong> the treatment of choice [4-5,11,13]. Oral<br />

doses ranged from 0.5 to 1mg/kg/day f<strong>or</strong> a period of 4-5<br />

months, rem<strong>is</strong>sion of the symptoms of facial and nasal<br />

colonization <strong>is</strong> achieved since the first three months of<br />

treatment [5]. The therapeutic success of <strong>is</strong>otretinoin in<br />

the GNF <strong>is</strong> due to decreased secretion of the sebaceous<br />

glands (thereby reducing the amount of sebum in m<strong>or</strong>e<br />

than 90%) and reduction of the follicular space size and<br />

anti-inflammat<strong>or</strong>y effect, returning the environment<br />

uninhab<strong>it</strong>able f<strong>or</strong> <strong>Gram</strong>-<strong>negative</strong> bacteria [5,8]. The most<br />

effective dose w<strong>it</strong>h a lower recurrence rate <strong>is</strong> 1mg/kg/day<br />

[4,11,13].<br />

Systemic antibiotics such as cephalosp<strong>or</strong>ins combined<br />

w<strong>it</strong>h <strong>or</strong>al <strong>is</strong>otretinoin f<strong>or</strong> 2 weeks are often useful on<br />

patients w<strong>it</strong>h frequent relapses [4]. Ampicillin and<br />

trimethoprim-sulfamethoxazole are rep<strong>or</strong>ted w<strong>it</strong>h good<br />

results w<strong>it</strong>h rem<strong>is</strong>sion of lesions in two weeks, w<strong>it</strong>h<br />

subsequent gradual reduction in dose. The clinical course<br />

determines the time of w<strong>it</strong>hdrawal, w<strong>it</strong>h rem<strong>is</strong>sion rates<br />

ranged from 4 to 48 months [3] (Tab. I).<br />

Finally, we concluded the gram-<strong>negative</strong> <strong>follicul<strong>it</strong><strong>is</strong></strong> <strong>is</strong> an<br />

underdiagnosed d<strong>is</strong>ease, probably because the increased<br />

use of <strong>or</strong>al <strong>is</strong>otretinoin f<strong>or</strong> acne management. We must<br />

suspected <strong>it</strong> when there <strong>is</strong> an exacerbation of centrofacial<br />

papules, pustules and/<strong>or</strong> nodules and cyst in patients<br />

w<strong>it</strong>h inflammat<strong>or</strong>y acne <strong>or</strong> rosacea that have long<br />

treatments w<strong>it</strong>h broad spectrum antibiotics, nonresponding<br />

to conventional treatments. We must request<br />

the bacteriological studies bef<strong>or</strong>e in<strong>it</strong>iating the <strong>or</strong>al<br />

<strong>is</strong>otretinoin.<br />

L<strong>it</strong>erature Patients Clinical Status Agent Treatment<br />

Reference<br />

Neubert et al 10 n= 46 Centrofacial<br />

<strong>follicul<strong>it</strong><strong>is</strong></strong> combined<br />

w<strong>it</strong>h open and/<strong>or</strong><br />

closed comedon.<br />

Klebsiella spp.,<br />

Escherichia coli,<br />

Enterobacter spp.,<br />

and Proteus spp.<br />

Isotretinoin, mean duration<br />

18.6 weeks, mean total<br />

dosage 109 mg/kg.<br />

James et al 5 n=21 Patients w<strong>it</strong>h<br />

nodulocystic acne<br />

w<strong>it</strong>h several facial<br />

pustules res<strong>is</strong>tant to<br />

all therapies.<br />

Escherichia<br />

aerogenes.<br />

Isotretinoin 0.48-0.74<br />

mg/kg/day f<strong>or</strong> 20 weeks.<br />

© N Dermatol Online 3.2011<br />

137

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!